{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:37:52Z","timestamp":1787564272682,"version":"build-2736575974"},"reference-count":20,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Structurally similar double-point modified analogues of 1,25-dihydroxyvitamin D2 (1,25D2) were screened in vitro for their pro-differentiating activity against the promyeloid cell line HL60. Their affinities towards human full length vitamin D receptor (VDR) and metabolic stability against human vitamin D 24-hydroxylase (CYP24A1) were also tested. The analogues (PRI-1730, PRI-1731, PRI-1732, PRI-1733 and PRI-1734) contained 5,6-trans modification of the A-ring and of the triene system, additional hydroxyl or unsaturation at C-22 in the side chain and reversed absolute configuration (24-epi) at C-24 of 1,25D2. As presented in this paper, introduction of selected structural modifications simultaneously in two distinct parts of the vitamin D molecule resulted in a divergent group of analogues. Analogues showed lower VDR affinity in comparison to that of the parent hormones, 1,25D2 and 1,25D3, and they caused effective HL60 cell differentiation only at high concentrations of 100 nM and above. Unexpectedly, introducing of a 5,6-trans modification combined with C-22 hydroxyl and 24-epi configuration switched off entirely the cell differentiation activity of the analogue (PRI-1734). However, this analogue remained a moderate substrate for CYP24A1, as it was metabolized at 22%, compared to 35% for 1,25D2. Other analogues from this series were either less (12% for PRI-1731 and PRI-1733) or more (52% for PRI-1732) resistant to the enzymatic deactivation. Although the inactive analogue PRI-1734 failed to show VDR antagonism, when tested in HL60 cells, its structure might be a good starting point for our design of a vitamin D antagonist.<\/jats:p>","DOI":"10.3390\/ijms17020091","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T10:03:26Z","timestamp":1454321006000},"page":"91","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D2 as Potential Anti-Leukemic Agents"],"prefix":"10.3390","volume":"17","author":[{"given":"Aoife","family":"Corcoran","sequence":"first","affiliation":[{"name":"Faculty of Biotechnology, University of Wroclaw, 14a Joliot-Curie, Wroclaw 50-383, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmin","family":"Nadkarni","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Institute, 8 Rydygiera, Warsaw 01-793, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sakaki","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Brown","sequence":"additional","affiliation":[{"name":"School of Immunity and Infection, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, West Midlands B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kutner","sequence":"additional","affiliation":[{"name":"Pharmaceutical Research Institute, 8 Rydygiera, Warsaw 01-793, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-5464","authenticated-orcid":false,"given":"Ewa","family":"Marcinkowska","sequence":"additional","affiliation":[{"name":"Faculty of Biotechnology, University of Wroclaw, 14a Joliot-Curie, Wroclaw 50-383, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jn\/126.suppl_4.1159S","article-title":"Vitamin D and bone health","volume":"126","author":"Holick","year":"1996","journal-title":"J. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e3181c51ee6","article-title":"Vitamin D: Considerations in the continued development as an agent for cancer prevention and therapy","volume":"16","author":"Trump","year":"2010","journal-title":"Cancer J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts","volume":"97","author":"Mathieu","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/84.4.694","article-title":"The case against ergocalciferol (vitamin D2) as a vitamin supplement","volume":"84","author":"Houghton","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1185\/03007990902844097","article-title":"Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: A US perspective","volume":"25","author":"Nuijten","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.leukres.2005.04.003","article-title":"Vitamin D2 analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome","volume":"29","author":"Koeffler","year":"2005","journal-title":"Leuk. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Harrison, J.S., and Bershadskiy, A. Clinical experience using vitamin D and analogs in the treatment of myelodysplasia and acute myeloid leukemia: A review of the literature. Leuk. Res. Treat., 2012.","DOI":"10.1155\/2012\/125814"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.leukres.2014.03.009","article-title":"Monocytic differentiation induced by side-chain modified analogs of vitamin D in ex vivo ex vivo cells from patients with acute myeloid leukemia","volume":"38","author":"Baurska","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jsbmb.2011.04.006","article-title":"Structure-function analysis of vitamin D2 analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation","volume":"126","author":"Baurska","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Corcoran, A., Bermudez, M.A., Seoane, S., Perez-Fernandez, R., Krupa, M., Pietraszek, A., Chody\u0144ski, M., Kutner, A., Brown, G., and Marcinkowska, E. (2015). Biological evaluation of new vitamin D2 analogues. J. Steroid Biochem. Mol. Biol.","DOI":"10.1016\/j.jsbmb.2015.09.033"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-12-381978-9.10007-1","article-title":"The vitamin D receptor: Biochemical, molecular, biological, and genomic era investigations","volume":"1","author":"Pike","year":"2011","journal-title":"Vitam. D"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jsbmb.2013.11.004","article-title":"Fundamentals of vitamin D hormone-regulated gene expression","volume":"114","author":"Pike","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.03.080","article-title":"CYP24A1 splice variants--implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer","volume":"121","author":"Khabir","year":"2010","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nadkarni, S., Chody\u0144ski, M., Krajewski, K., Cmoch, P., Marcinkowska, E., Brown, G., and Kutner, A. (2015). Convergent synthesis of double point modified analogs of 1\u03b1,25-dihydroxyvitamin D2 for biological evaluation. J. Steroid Biochem. Mol. Biol.","DOI":"10.1016\/j.jsbmb.2015.08.022"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbrc.2004.07.040","article-title":"Metabolism of A-ring diastereomers of 1\u03b1,25-dihydroxyvitamin D3 by CYP24A1","volume":"321","author":"Kusudo","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2009.04.075","article-title":"Metabolism of 1\u03b1,25-dihydroxyvitamin D2 by human CYP24A1","volume":"384","author":"Urushino","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bolla, N.R., Corcoran, A., Yasuda, K., Chody\u0144ski, M., Krajewski, K., Cmoch, P., Marcinkowska, E., Brown, G., Sakaki, T., and Kutner, A. (2015). Synthesis and evaluation of geometric analogs of 1\u03b1,25-dihydroxyvitamin D2 as potential therapeutics. J. Steroid Biochem. Mol. Biol.","DOI":"10.1016\/j.jsbmb.2015.08.025"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2174\/1381612821666141205125113","article-title":"Double point modified analogs of vitamin d as potent activators of vitamin D receptor","volume":"21","author":"Nadkarni","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.steroids.2008.06.010","article-title":"Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential","volume":"73","author":"Gocek","year":"2008","journal-title":"Steroids"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3892\/or.2012.1886","article-title":"Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2","volume":"28","author":"Baurska","year":"2012","journal-title":"Oncol. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/2\/91\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:18:37Z","timestamp":1760210317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/2\/91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["ijms17020091"],"URL":"https:\/\/doi.org\/10.3390\/ijms17020091","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]}}}